Dasatinib and the Risk of Pulmonary Arterial Hypertension

Published Online: Friday, October 21, 2011
Follow Pharmacy_Times:
In this podcast, Jennifer Shepherd, a pharmacist in the FDA’s Division of Drug Information, discusses the increased risk of pulmonary arterial hypertension associated with Sprycel (dasatinib), a drug indicated to treat leukemia.

To access the podcast, click here.
Related Articles
Why is there still a big divide on whether a residency can benefit a pharmacy career?
The following tips will ensure you appropriately manage your finances after graduation.
Ferris State University has received a $1.5 million gift from alumni Jeff and Annette Rowe for the College of Pharmacy.
Peter J. Rice, PharmD, PhD, BCPS, discusses how the role of the pharmacist has changed.
Latest Issues
  • photo
    Pharmacy Times
    photo
    Health-System Edition
    photo
    Directions in Pharmacy
    photo
    OTC Guide
    photo
    Generic Supplements
  • photo
    Pharmacy Careers
    photo
    Specialty Pharmacy Times
    photo
    Generic
$auto_registration$